Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity
Odor identification deficits are well documented in patients with schizophrenia, but it remains unclear whether individuals at clinical high-risk for psychosis exhibit similar changes and whether their olfactory function is related to social/cognitive functions and symptomatology. In this study, we investigated odor detection sensitivity and identification ability in 32 individuals with at-risk mental state (ARMS), 59 schizophrenia patients, and 169 healthy controls using a T&T olfactometer. The ARMS and schizophrenia subjects were administered the Brief Assessment of Cognition in Schizophrenia (BACS), the Schizophrenia Cognition Rating Scale (SCoRS), and the Social and Occupational Functioning Assessment Scale (SOFAS) to assess their cognitive and social functions, and the Positive and Negative Syndrome Scale (PANSS) for clinical symptoms. Both the ARMS and schizophrenia subjects had lower odor identification ability when compared with healthy controls, while no significant difference was found in the odor detection sensitivity. The lower odor identification ability in the ARMS group correlated with the severity of negative symptoms and weakly correlated with lower performance on the BACS verbal fluency test. The olfactory measures of schizophrenia patients did not correlate with illness duration, medication, symptom severity, and social and cognitive functions. For the ARMS and schizophrenia groups, the olfactory measures did not correlate with the SOFAS and SCoRS scores. These findings suggest that high-risk subjects for psychosis already show odor identification deficits similar to those observed in schizophrenia patients, which probably reflect a biological trait related to vulnerability to psychosis.
KeywordsOlfaction High-risk Psychosis Schizophrenia Negative symptoms Cognition
This work was supported by JSPS KAKENHI Grant Number JP26461739 to Dr. Takahashi and JP24390281 to Prof. Suzuki and by the Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development (AMED) Grant Number 16dk0307029h0003 to Prof. Suzuki. The funding agencies had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data, or preparation, review and approval of the manuscript.
Compliance with ethical standards
Conflict of interest
There are no conflicts of interest for any of the authors including any financial, personal or other relationships with other people or organizations within 3 years of beginning the submitted work that could inappropriately influence, or be perceived to influence, our work.
- 21.Brewer WJ, Wood SJ, McGorry PD, Francey SM, Phillips LJ, Yung AR, Anderson V, Copolov DL, Singh B, Velakoulis D, Pantelis C (2003) Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry 160:1790–1794CrossRefPubMedGoogle Scholar
- 29.American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DCGoogle Scholar
- 30.First MB, Gibbon M, Spitzer RL, Williams JBW (1997) Structured clinical interview for DSM-IV Axis I disorders. American Psychiatric Press, Washington DCGoogle Scholar
- 32.Okada N, Kasai K, Takahashi T, Suzuki M, Hashimoto R, Kameyama T, Hiramatsu K, Saito O, Niwa S (2014) Rating scale of handedness for biological psychiatry research among Japanese people. Jpn J Biol Psychiatry 25:118–119Google Scholar
- 33.Okada N, Kasai K, Takahashi T, Suzuki M, Hashimoto R, Kawakami N (2014) Brief rating scale of socioeconomic status for biological psychiatry research among Japanese people: a scaling based on an educational history. Jpn J Biol Psychiatry 25:115–117Google Scholar
- 43.Higuchi Y, Sumiyoshi T, Seo T, Suga M, Takahashi T, Nishiyama S, Komori Y, Kasai K, Suzuki M (2017) Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; A study with the Schizophrenia Cognition Rating Scale Japanese version. Schizophr Res Cogn 7:13–18CrossRefPubMedPubMedCentralGoogle Scholar
- 45.Toru M (2008) Psychotropic manual, 3rd edn. Igaku-Shoin, TokyoGoogle Scholar
- 49.Horiuchi Y, Kondo MA, Okada K, Takayanagi Y, Tanaka T, Ho T, Varvaris M, Tajinda K, Hiyama H, Ni K, Colantuoni C, Schretlen D, Cascella NG, Pevsner J, Ishizuka K, Sawa A (2016) Molecular signatures associated with cognitive deficits in schizophrenia: a study of biopsied olfactory neural epithelium. Transl Psychiatry 6:e915CrossRefPubMedPubMedCentralGoogle Scholar
- 53.Rupp CI, Fleischhacker WW, Kemmler G, Kremser C, Bilder RM, Mechtcheriakov S, Szeszko PR, Walch T, Scholtz AW, Klimbacher M, Maier C, Albrecht G, Lechner-Schoner T, Felber S, Hinterhuber H (2005) Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophrenia. Schizophr Res 74:149–161CrossRefPubMedGoogle Scholar
- 58.Kiparizoska S, Ikuta T (2017) Disrupted Olfactory Integration in Schizophrenia: Functional Connectivity Study. Int J Neuropsychopharmacol, in pressGoogle Scholar
- 63.Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire PK (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281–288CrossRefPubMedGoogle Scholar
- 68.Hauser M, Zhang JP, Sheridan EM, Burdick KE, Mogil R, Kane JM, Auther A, Carrión RE, Cornblatt BA, Correll CU (2017) Neuropsychological test performance to enhance identification of subjects at clinical high risk for psychosis and to be most promising for predictive algorithms for conversion to psychosis: a meta-analysis. J Clin Psychiatry 78:e28–e40CrossRefPubMedGoogle Scholar
- 69.Sawada K, Kanehara A, Sakakibara E, Eguchi S, Tada M, Satomura Y, Suga M, Koike S, Kasai K (2017) Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis. Psychiatry Clin Neurosci 71:318–327CrossRefPubMedGoogle Scholar